Analysis of HIV-1 subtype B third variable region peptide motifs for induction of neutralizing antibodies against HIV-1 primary isolates

被引:33
作者
Haynes, BF
Ma, BJ
Montefiori, DC
Wrin, T
Petropoulos, CJ
Sutherland, LL
Scearce, RM
Denton, C
Xia, SM
Korber, BT
Liao, HX
机构
[1] Duke Univ, Med Ctr, Dept Med, Sch Med, Durham, NC 27710 USA
[2] Duke Univ, Sch Med, Human Vaccine Inst, Durham, NC 27710 USA
[3] Duke Univ, Dept Surg, Sch Med, Durham, NC 27710 USA
[4] Los Alamos Natl Lab, Los Alamos, NM 87545 USA
[5] Santa Fe Inst, Santa Fe, NM 87501 USA
[6] Virolog Inc, San Francisco, CA 94080 USA
关键词
HIV-1; vaccine; envelope; V3; loop; neutralization; antibody; peptide; immunogen; guinea pig;
D O I
10.1016/j.virol.2005.08.042
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The HIV-1 gp120 V3 loop is a potent inducer of neutralizing antibodies for T cell line adapted-HIV-1, but less so for primary isolates. We hypothesized that peptides representative of the diversity of natural HIV-1 V3 loop variants might capture elements of conserved higher order structures and so stimulate broadly reactive neutralizing antibodies. We designed a panel of 29 subtype B V3 sequences postulated to reflect the range of V3 diversity. These peptides were used to immunize guinea pigs. The most effective peptide (62.19) clustered around the subtype B consensus sequence and induced antibodies that reproducibly neutralized 31% of the subtype B HIV-1 primary isolates evaluated, but exhibited limited cross-neutralization of non-subtype B HIV-1 strains. Taken together, these data demonstrated that the limited neutralization profile of antibodies induced by optimal subtype B V3 motifs likely represents the maximum breadth of neutralization of subtype B HIV-1 primary isolates attainable by anti-V3 peptide antibodies. (C) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:44 / 55
页数:12
相关论文
共 42 条
[1]   Safety and immunogenicity of an HLA-based HIV envelope polyvalent synthetic peptide immunogen [J].
Bartlett, JA ;
Wasserman, SS ;
Hicks, CB ;
Dodge, RT ;
Weinhold, KJ ;
Tacket, CO ;
Ketter, N ;
Wittek, AE ;
Palker, TJ ;
Haynes, BF .
AIDS, 1998, 12 (11) :1291-1300
[2]   Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies [J].
Binley, JA ;
Wrin, T ;
Korber, B ;
Zwick, MB ;
Wang, M ;
Chappey, C ;
Stiegler, G ;
Kunert, R ;
Zolla-Pazner, S ;
Katinger, H ;
Petropoulos, CJ ;
Burton, DR .
JOURNAL OF VIROLOGY, 2004, 78 (23) :13232-13252
[3]   CRYPTIC NATURE OF ENVELOPE V3 REGION EPITOPES PROTECTS PRIMARY MONOCYTOTROPIC HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 FROM ANTIBODY NEUTRALIZATION [J].
BOUHABIB, DC ;
RODERIQUEZ, G ;
ORAVECZ, T ;
BERMAN, PW ;
LUSSO, P ;
NORCROSS, MA .
JOURNAL OF VIROLOGY, 1994, 68 (09) :6006-6013
[4]   Regional clustering of shared neutralization determinants on primary isolates of clade C human immunodeficiency virus type 1 from South Africa [J].
Bures, R ;
Morris, L ;
Williamson, C ;
Ramjee, G ;
Deers, M ;
Fiscus, SA ;
Abdool Karim, SS ;
Montefiori, DC .
JOURNAL OF VIROLOGY, 2002, 76 (05) :2233-2244
[5]   Structure and polymorphism of HIV-1 third variable loops [J].
Catasti, P ;
Bradbury, EM ;
Gupta, G .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (14) :8236-8242
[6]   MACROPHAGE-TROPIC HUMAN-IMMUNODEFICIENCY-VIRUS ISOLATES FROM DIFFERENT PATIENTS EXHIBIT UNUSUAL V3 ENVELOPE SEQUENCE HOMOGENEITY IN COMPARISON WITH T-CELL-TROPIC ISOLATES - DEFINITION OF CRITICAL AMINO-ACIDS INVOLVED IN CELL TROPISM [J].
CHESEBRO, B ;
WEHRLY, K ;
NISHIO, J ;
PERRYMAN, S .
JOURNAL OF VIROLOGY, 1992, 66 (11) :6547-6554
[7]   NEUTRALIZATION OF PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ISOLATES BY THE BROADLY REACTIVE ANTI-V3 MONOCLONAL-ANTIBODY, 447-52D [J].
CONLEY, AJ ;
GORNY, MK ;
KESSLER, JA ;
BOOTS, LJ ;
OSSORIOCASTRO, M ;
KOENIG, S ;
LINEBERGER, DW ;
EMINI, EA ;
WILLIAMS, C ;
ZOLLAPAZNER, S .
JOURNAL OF VIROLOGY, 1994, 68 (11) :6994-7000
[8]   MINIMAL REQUIREMENTS FOR THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 V3 DOMAIN TO SUPPORT THE SYNCYTIUM-INDUCING PHENOTYPE - ANALYSIS BY SINGLE AMINO-ACID SUBSTITUTION [J].
DEJONG, JJ ;
DERONDE, A ;
KEULEN, W ;
TERSMETTE, M ;
GOUDSMIT, J .
JOURNAL OF VIROLOGY, 1992, 66 (11) :6777-6780
[9]   HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) ANTIGENS - STRUCTURE AND SEROLOGY OF MULTIVALENT HUMAN MUCIN MUC1-HIV V3 CHIMERIC PROTEINS [J].
FONTENOT, JD ;
GATEWOOD, JM ;
MARIAPPAN, SVS ;
PAU, CP ;
PAREKH, BS ;
GEORGE, JR ;
GUPTA, G .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (01) :315-319
[10]   PHENOTYPE-ASSOCIATED SEQUENCE VARIATION IN THE 3RD VARIABLE DOMAIN OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GP120 MOLECULE [J].
FOUCHIER, RAM ;
GROENINK, M ;
KOOTSTRA, NA ;
TERSMETTE, M ;
HUISMAN, HG ;
MIEDEMA, F ;
SCHUITEMAKER, H .
JOURNAL OF VIROLOGY, 1992, 66 (05) :3183-3187